We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00685230
Recruitment Status : Completed
First Posted : May 28, 2008
Last Update Posted : June 2, 2011
University of Arizona
Universidad Nacional Autonoma de Mexico
Information provided by:
Instituto Bioclon S.A. de C.V.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : August 2005
  Study Completion Date : October 2005

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 10, 2011 July 12, 2011
2 January 9, 2012 February 8, 2012
3 November 19, 2015 December 22, 2015
4 January 18, 2016 February 12, 2016
5 March 18, 2016 April 19, 2016